Myriad Genetics (MYGN) ROIC: History & Chart

Name: Myriad Genetics, Inc. (MYGN) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

Myriad Genetics, Inc.(MYGN)

Medical - Diagnostics & Research · Salt Lake City, UT

$4.41-0.17 (-3.82%)

Delayed quote: Oct 6, 2026, 1:05 PM EDT

Compare

About Myriad Genetics, Inc.

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children’s Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Salt Lake City, UT

2,700 employees

www.myriad.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Samraat S. Raha

View full financials

MYGN Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

-19.13%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

-61.70%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

-36.42%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

-17.39%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

-7.95%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

1.11%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

3.40%

CURRENT VS TTM AVG

+69.00%

CURRENT VS 3Y AVG

+47.48%

CURRENT VS 5Y AVG

-9.98%

CURRENT VS 10Y AVG

-140.60%

CURRENT VS 15Y AVG

-1830.67%

CURRENT VS 20Y AVG

-661.84%

SECTOR MEDIAN · HEALTHCARE

-34.44%

median of 766 covered companies

CURRENT VS SECTOR MEDIAN

+44.45%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Myriad Genetics, Inc. (MYGN)	$416.04M	-19.13%	-61.70%	-36.42%	-17.39%
Senseonics Holdings, Inc. (SENS)vs ›	$418.36M	-71.22%	-79.15%	-65.81%	-107.73%
Prothena Corporation plc (PRTA)vs ›	$413.10M	-21.36%	-47.45%	-35.84%	-28.07%
Rezolute, Inc. (RZLT)vs ›	$412.95M	-81.80%	-65.32%	-58.77%	-53.22%
Strata Critical Medical, Inc. (SRTA)vs ›	$410.81M	-7.11%	-10.90%	-16.50%	-14.69%
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$410.64M	-46.16%	-62.80%	-62.80%	-62.80%
ARS Pharmaceuticals, Inc. (SPRY)vs ›	$422.04M	-114.65%	-31.55%	-26.30%	-23.63%
Shoulder Innovations, Inc. (SI)vs ›	$409.37M	-25.26%	-29.12%	-26.65%	-26.65%
Neurogene Inc. (NGNE)vs ›	$409.04M	-54.45%	-31.52%	-36.49%	-36.90%
Atea Pharmaceuticals, Inc. (AVIR)vs ›	$408.54M	-89.93%	-54.36%	-39.52%	-23.86%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Myriad Genetics, Inc. (MYGN)

$416.04M

-19.13%

-61.70%

-36.42%

-17.39%

Senseonics Holdings, Inc. (SENS)vs ›

$418.36M

-71.22%

-79.15%

-65.81%

-107.73%

Prothena Corporation plc (PRTA)vs ›

$413.10M

-21.36%

-47.45%

-35.84%

-28.07%

Rezolute, Inc. (RZLT)vs ›

$412.95M

-81.80%

-65.32%

-58.77%

-53.22%

Strata Critical Medical, Inc. (SRTA)vs ›

$410.81M

-7.11%

-10.90%

-16.50%

-14.69%

Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›

$410.64M

-46.16%

-62.80%

ARS Pharmaceuticals, Inc. (SPRY)vs ›

$422.04M

-114.65%

-31.55%

-26.30%

-23.63%

Shoulder Innovations, Inc. (SI)vs ›

$409.37M

-25.26%

-29.12%

-26.65%

Neurogene Inc. (NGNE)vs ›

$409.04M

-54.45%

-31.52%

-36.49%

-36.90%

Atea Pharmaceuticals, Inc. (AVIR)vs ›

$408.54M

-89.93%

-54.36%

-39.52%

-23.86%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Myriad Genetics, Inc. (MYGN)?

The return on invested capital (ROIC) for MYGN stock is -19.13%.

Is Myriad Genetics, Inc.'s return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of -19.13% is in line with its 5-year average of -17.39%, near the high end of its 5-year range (-77.72%–-8.97%).

What is the TTM average return on invested capital (ROIC) for Myriad Genetics, Inc. (MYGN)?

The TTM average return on invested capital (ROIC) for MYGN stock is -61.70%.

What is the 3Y average return on invested capital (ROIC) for Myriad Genetics, Inc. (MYGN)?

The 3Y average return on invested capital (ROIC) for MYGN stock is -36.42%.

What is the 5Y average return on invested capital (ROIC) for Myriad Genetics, Inc. (MYGN)?

The 5Y average return on invested capital (ROIC) for MYGN stock is -17.39%.

What is the 10Y average return on invested capital (ROIC) for Myriad Genetics, Inc. (MYGN)?

The 10Y average return on invested capital (ROIC) for MYGN stock is -7.95%.

What is the 15Y average return on invested capital (ROIC) for Myriad Genetics, Inc. (MYGN)?

The 15Y average return on invested capital (ROIC) for MYGN stock is 1.11%.

What is the 20Y average return on invested capital (ROIC) for Myriad Genetics, Inc. (MYGN)?

The 20Y average return on invested capital (ROIC) for MYGN stock is 3.40%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	-19.13%
2026-03-31	-71.55%
2025-12-31	-67.60%
2025-09-30	-72.49%
2025-06-30	-77.72%
2025-03-31	-14.56%
2024-12-31	-14.29%
2024-09-30	-12.49%
2024-06-30	-16.65%
2024-03-31	-24.17%
2023-12-31	-25.98%
2023-09-30	-29.60%
2023-06-30	-27.23%
2023-03-31	-16.30%
2022-12-31	-13.25%
2022-09-30	-12.14%
2022-06-30	-15.26%
2022-03-31	-15.55%
2021-12-31	-17.06%
2021-09-30	-13.01%
2021-06-30	-8.97%
2021-03-31	-13.01%
2020-12-31	-18.78%
2020-09-30	-19.10%
2020-06-30	-18.42%
2020-03-31	-12.67%
2019-12-31	-2.01%
2019-09-30	-0.98%
2019-06-30	0.53%
2019-03-31	1.34%
2018-12-31	1.32%
2018-09-30	2.12%
2018-06-30	10.60%
2018-03-31	10.77%
2017-12-31	10.76%
2017-09-30	9.59%
2017-06-30	2.63%
2017-03-31	4.59%
2016-12-31	6.57%
2016-09-30	8.86%
2016-06-30	16.81%
2016-03-31	15.05%
2015-12-31	13.42%
2015-09-30	12.89%
2015-06-30	11.42%
2015-03-31	13.29%
2014-12-31	15.03%
2014-09-30	18.24%
2014-06-30	23.42%
2014-03-31	24.61%
2013-12-31	26.81%
2013-09-30	24.09%
2013-06-30	19.45%
2013-03-31	19.10%
2012-12-31	17.96%
2012-09-30	17.67%
2012-06-30	16.97%
2012-03-31	16.16%
2011-12-31	16.90%
2011-09-30	17.38%
2011-06-30	17.27%
2011-03-31	23.57%
2010-12-31	22.84%
2010-09-30	24.11%
2010-06-30	23.85%
2010-03-31	29.52%
2009-12-31	33.02%
2009-09-30	36.04%
2009-06-30	35.65%
2009-03-31	25.31%
2008-12-31	20.09%
2008-09-30	12.94%
2008-06-30	8.95%
2008-03-31	-11.44%
2007-12-31	-11.93%
2007-09-30	-6.31%
2007-06-30	-7.34%
2007-03-31	-7.87%
2006-12-31	-12.54%
2006-09-30	-21.07%
2006-06-30	-18.25%
2006-03-31	-15.72%
2005-12-31	-14.95%
2005-09-30	-31.47%
2005-06-30	-30.03%
2005-03-31	-29.80%
2004-12-31	-28.17%
2004-09-30	-26.33%
2004-06-30	-24.61%
2004-03-31	-29.51%
2003-12-31	-23.83%
2003-09-30	-20.45%
2003-06-30	-16.73%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

-19.13%

2026-03-31

-71.55%

2025-12-31

-67.60%

2025-09-30

-72.49%

2025-06-30

-77.72%

2025-03-31

-14.56%

2024-12-31

-14.29%

2024-09-30

-12.49%

2024-06-30

-16.65%

2024-03-31

-24.17%

2023-12-31

-25.98%

2023-09-30

-29.60%

2023-06-30

-27.23%

2023-03-31

-16.30%

2022-12-31

-13.25%

2022-09-30

-12.14%

2022-06-30

-15.26%

2022-03-31

-15.55%

2021-12-31

-17.06%

2021-09-30

-13.01%

2021-06-30

-8.97%

2021-03-31

-13.01%

2020-12-31

-18.78%

2020-09-30

-19.10%

2020-06-30

-18.42%

2020-03-31

-12.67%

2019-12-31

-2.01%

2019-09-30

-0.98%

2019-06-30

0.53%

2019-03-31

1.34%

2018-12-31

1.32%

2018-09-30

2.12%

2018-06-30

10.60%

2018-03-31

10.77%

2017-12-31

10.76%

2017-09-30

9.59%

2017-06-30

2.63%

2017-03-31

4.59%

2016-12-31

6.57%

2016-09-30

8.86%

2016-06-30

16.81%

2016-03-31

15.05%

2015-12-31

13.42%

2015-09-30

12.89%

2015-06-30

11.42%

2015-03-31

13.29%

2014-12-31

15.03%

2014-09-30

18.24%

2014-06-30

23.42%

2014-03-31

24.61%

2013-12-31

26.81%

2013-09-30

24.09%

2013-06-30

19.45%

2013-03-31

19.10%

2012-12-31

17.96%

2012-09-30

17.67%

2012-06-30

16.97%

2012-03-31

16.16%

2011-12-31

16.90%

2011-09-30

17.38%

2011-06-30

17.27%

2011-03-31

23.57%

2010-12-31

22.84%

2010-09-30

24.11%

2010-06-30

23.85%

2010-03-31

29.52%

2009-12-31

33.02%

2009-09-30

36.04%

2009-06-30

35.65%

2009-03-31

25.31%

2008-12-31

20.09%

2008-09-30

12.94%

2008-06-30

8.95%

2008-03-31

-11.44%

2007-12-31

-11.93%

2007-09-30

-6.31%

2007-06-30

-7.34%

2007-03-31

-7.87%

2006-12-31

-12.54%

2006-09-30

-21.07%

2006-06-30

-18.25%

2006-03-31

-15.72%

2005-12-31

-14.95%

2005-09-30

-31.47%

2005-06-30

-30.03%

2005-03-31

-29.80%

2004-12-31

-28.17%

2004-09-30

-26.33%

2004-06-30

-24.61%

2004-03-31

-29.51%

2003-12-31

-23.83%

2003-09-30

-20.45%

2003-06-30

-16.73%

Return on Invested Capital (ROIC): -19.13%

MYGN Return on Invested Capital (ROIC)

MYGN Average Return on Invested Capital (ROIC) Chart

MYGN Current vs Average Return on Invested Capital (ROIC) Chart

MYGN Return on Invested Capital (ROIC) Metrics

MYGN Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

MYGN Return on Invested Capital (ROIC) History

Related Metrics